Shenzhen Hepalink Pharmaceutical Group Revenue

Shenzhen Hepalink Pharmaceutical Group had revenue of 1.23B CNY in the quarter ending September 30, 2024, a decrease of -8.80%. This brings the company's revenue in the last twelve months to 5.45B, down -6.46% year-over-year. In the year 2023, Shenzhen Hepalink Pharmaceutical Group had annual revenue of 5.45B, down -23.94%.

Revenue (ttm)

5.45B CNY

Revenue Growth

-6.46%

P/S Ratio

n/a

Revenue / Employee

2.62M CNY

Employees

2,080

Market Cap

16.63B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.45B	-1.71B	-23.94%
Jan 1, 2023	7.16B	794.23M	12.48%
Jan 1, 2022	6.37B	1.03B	19.38%
Dec 31, 2020	5.33B	707.42M	15.30%
Dec 31, 2019	4.62B	-190.31M	-3.95%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition